Teladoc Health (NYSE:TDOC) Now Covered by The Goldman Sachs Group

The Goldman Sachs Group initiated coverage on shares of Teladoc Health (NYSE:TDOC) in a report released on Friday morning, MarketBeat reports. The brokerage issued a buy rating and a $14.00 price objective on the health services provider’s stock.

TDOC has been the topic of several other reports. Truist Financial decreased their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research report on Friday, August 2nd. Oppenheimer decreased their price objective on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating on the stock in a research report on Thursday, August 1st. Piper Sandler dropped their target price on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. DA Davidson cut their target price on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a research report on Thursday, August 1st. Finally, Evercore ISI raised their price target on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Fourteen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $12.08.

Teladoc Health Price Performance

NYSE:TDOC opened at $9.06 on Friday. The company has a market capitalization of $1.56 billion, a P/E ratio of -1.57 and a beta of 0.90. The business’s 50-day moving average is $8.93 and its 200 day moving average is $9.34. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $22.54.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. On average, equities research analysts forecast that Teladoc Health will post -1.17 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Thomas Mckinley acquired 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the purchase, the director now directly owns 39,077 shares of the company’s stock, valued at $300,502.13. This trade represents a 11.40 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Mala Murthy sold 8,750 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $62,650.00. Following the sale, the chief financial officer now directly owns 85,767 shares in the company, valued at approximately $614,091.72. The trade was a 9.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 20,051 shares of company stock valued at $143,565 over the last three months. 0.95% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

Several hedge funds have recently modified their holdings of the company. Signaturefd LLC raised its stake in shares of Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,715 shares in the last quarter. International Assets Investment Management LLC purchased a new position in Teladoc Health in the second quarter worth $29,000. Blue Trust Inc. increased its position in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares in the last quarter. Doheny Asset Management CA purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at $46,000. Finally, SageView Advisory Group LLC acquired a new stake in shares of Teladoc Health in the 1st quarter worth $48,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.